Genetic research in nephrology is rapidly advancing. Key studies published in 2020 demonstrate that genetic findings can provide new tools for patient diagnosis and risk stratification as well as important insights into kidney physiology and disease mechanisms that could potentially lead to novel therapies.
Key advances
-
A genome-wide association study (GWAS) of membranous nephropathy identifies novel loci and validates a genetic risk score that could improve diagnosis of this rare disease1.
-
GWAS that integrate genomic and metabolomic data from patients with chronic kidney disease identify novel candidate mechanisms of metabolite detoxification and excretion in the kidney3.
-
Analysis of the contributions of monogenic variants and polygenic risk scores to probability of disease in carriers of risk variants for tier 1 genomic conditions demonstrates that polygenic background modifies the risk of monogenic diseases4.
-
High-resolution imaging of uromodulin, which is encoded by an important kidney disease gene, identifies a potential mechanism by which this protein might defend against urinary tract infections8.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Complement catalyzing glomerular diseases
Cell and Tissue Research Open Access 01 August 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Xie, J. et al. The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. Nat. Commun. 11, 1600 (2020).
Stanescu, H. C. et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N. Engl. J. Med. 364, 616–626 (2011).
Schlosser, P. et al. Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans. Nat. Genet. 52, 167–176 (2020).
Fahed, A. C. et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat. Commun. 11, 3635 (2020).
Patel, A. P. et al. Association of rare pathogenic DNA variants for familial hypercholesterolemia, hereditary breast and ovarian cancer syndrome, and lynch syndrome with disease risk in adults according to family history. JAMA Netw. Open 3, e203959 (2020).
Khera, A. V. et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 50, 1219–1224 (2018).
Devuyst, O., Olinger, E. & Rampoldi, L. Uromodulin: from physiology to rare and complex kidney disorders. Nat. Rev. Nephrol. 13, 525–544 (2017).
Weiss, G. L. et al. Architecture and function of human uromodulin filaments in urinary tract infections. Science 369, 1005–1010 (2020).
Ghirotto, S. et al. The uromodulin gene locus shows evidence of pathogen adaptation through human evolution. J. Am. Soc. Nephrol. 27, 2983–2996 (2016).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Köttgen, A., Kiryluk, K. New genetic insights into kidney physiology and disease. Nat Rev Nephrol 17, 85–86 (2021). https://doi.org/10.1038/s41581-020-00383-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-020-00383-2
This article is cited by
-
Complement catalyzing glomerular diseases
Cell and Tissue Research (2021)